All the times Ackman’s $1 billion bet against Herbalife should have been unwound

An epic five-year crusade against nutritional-supplement company Herbalife Ltd. ended, with one of Wall Street’s more prominent hedge-fund luminaries finally coming to grips with another brutal investing defeat.